[1]
|
Durvasula, R. and Miller, T.R. (2014) Substance Abuse Treatment in Persons with HIV/AIDS: Challenges in Managing Triple Diagnosis. Behavioral Medicine, 40, 43-52. https://doi.org/10.1080/08964289.2013.866540
|
[2]
|
Wilson, T.W., Fox, H.S., Robertson, K.R., Sandkovsky, U., O’Neill, J., et al. (2013) Abnormal MEG Oscillatory Activity during Visual Processing in the Prefrontal Cortices and Frontal Eye-Fields of the Aging HIV Brain. PLoS ONE, 8, e66241. https://doi.org/10.1371/journal.pone.0066241
|
[3]
|
Fairfield, K.M., Eisenberg, D.M., Davis, R.B., Libman, H. and Phillips, R.S. (1998) Patterns of Use, Expenditures, and Perceived Efficacy of Complementary and Alternative Therapies in HIV-Infected Patients. Archives of Internal Medicine, 158, 2257-2264. https://doi.org/10.1001/archinte.158.20.2257
|
[4]
|
Prentiss, D., Power, R., Balmas, G., Tzuang, G. and Israelski, D.M. (2004) Patterns of Marijuana Use among Patients with HIV/AIDS Followed in a Public Health Care Setting. Journal of Acquired Immune Deficiency Syndromes, 35, 38-45. https://doi.org/10.1097/00126334-200401010-00005
|
[5]
|
Sidney, S. (2001) Marijuana Use in HIV-Positive and AIDS Patients: Results of an Anonymous Mail Survey. Journal of Cannabis Therapeutics, 1, 35-41. https://doi.org/10.1300/J175v01n03_04
|
[6]
|
Sohler, N.L., Wong, M.D., Cunningham, W.E., Cabral, H., Drainoni, M.L., et al. (2007) Type and Pattern of Illicit Drug Use and Access to Health Care Services for HIV-Infected People. AIDS Patient Care and STDs, 21, S68-S76. https://doi.org/10.1089/apc.2007.9985
|
[7]
|
Furler, M.D., Einarson, T.R., Millson, M., Walmsley, S. and Bendayan, R. (2004) Medicinal and Recreational Marijuana Use by Patients Infected with HIV. AIDS Patient Care and STDs, 18, 215-228. https://doi.org/10.1089/108729104323038892
|
[8]
|
Haney, M., Gunderson, E.W., Rabkin, J., Hart, C.L., Vosburg, S.K., et al. (2007) Dronabinol and Marijuana in HIV-Positive Marijuana Smokers. Caloric Intake, Mood, and Sleep. Journal of Acquired Immune Deficiency Syndromes, 45, 545-554. https://doi.org/10.1097/QAI.0b013e31811ed205
|
[9]
|
Ellis, R.J., Toperoff, W., Vaida, F., van den Brande, G., Gonzales, J., et al. (2009) Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial. Neuropsychopharmacology, 34, 672-680. https://doi.org/10.1038/npp.2008.120
|
[10]
|
Corless, I.B., Lindgren, T., Holzemer, W., Robinson, L., Moezzi, S., et al. (2009) Marijuana Effectiveness as an HIV Self-Care Strategy. Clinical Nursing Research, 18, 172-193. https://doi.org/10.1177/1054773809334958
|
[11]
|
Abrams, D.I., Jay, C.A., Shade, S.B., Vizoso, H., Reda, H., et al. (2007) Cannabis in Painful HIV-Associated Sensory Neuropathy: A Randomized Placebo-Controlled Trial. Neurology, 68, 515-521. https://doi.org/10.1212/01.wnl.0000253187.66183.9c
|
[12]
|
National Conference of State Legislatures (2020) State Medical Marijuana Laws. https://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx
|
[13]
|
National Conference of State Legislatures (2019) Marijuana Overview. https://www.ncsl.org/research/civil-and-criminal-justice/marijuana-overview.aspx
|
[14]
|
Hall, W. and Degenhardt, L. (2014) The Adverse Health Effects of Chronic Cannabis Use. Drug Testing and Analysis, 6, 39-45. https://doi.org/10.1002/dta.1506
|
[15]
|
Chang, L., Cloak, C., Yakupov, R. and Ernst, T. (2006) Combined and Independent Effects of Chronic Marijuana Use and HIV on Brain Metabolites. Journal of Neuroimmune Pharmacology, 1, 65-76. https://doi.org/10.1007/s11481-005-9005-z
|
[16]
|
Broyd, S.J., van Hell, H.H., Beale, C., Yucel, M. and Solowij, N. (2016) Acute and Chronic Effects of Cannabinoids on Human Cognition—A Systematic Review. Biological Psychiatry, 79, 557-567. https://doi.org/10.1016/j.biopsych.2015.12.002
|
[17]
|
Batalla, A., Crippa, J.A., Busatto, G.F., Guimaraes, F.S., Zuardi, A.W., et al. (2014) Neuroimaging Studies of Acute Effects of THC and CBD in Humans and Animals: a Systematic Review. Current Pharmaceutical Design, 20, 2168-2185. https://doi.org/10.2174/13816128113199990432
|
[18]
|
Batalla, A., Bhattacharyya, S., Yucel, M., Fusar-Poli, P., Crippa, J.A., et al. (2013) Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings. PLoS ONE, 8, e55821. https://doi.org/10.1371/journal.pone.0055821
|
[19]
|
Solowij, N., Stephens, R.S., Roffman, R.A., Babor, T., Kadden, R., et al. (2002) Cognitive Functioning of Long-Term Heavy Cannabis Users Seeking Treatment. JAMA, 287, 1123-1131. https://doi.org/10.1001/jama.287.9.1123
|
[20]
|
Thames, A.D., Mahmood, Z., Burggren, A.C., Karimian, A. and Kuhn, T.P. (2016) Combined Effects of HIV and Marijuana Use on Neurocognitive Functioning and Immune Status. AIDS Care, 28, 628-632. https://doi.org/10.1080/09540121.2015.1124983
|
[21]
|
Thames, A.D., Kuhn, T.P., Williamson, T.J., Jones, J.D., Mahmood, Z., et al. (2017) Marijuana Effects on Changes in Brain Structure and Cognitive Function among HIV+ and HIV- Adults. Drug and Alcohol Dependence, 170, 120-127. https://doi.org/10.1016/j.drugalcdep.2016.11.007
|
[22]
|
Lorkiewicz, S.A., Ventura, A.S., Heeren, T.C., Winter, M.R., Walley, A.Y., et al. (2018) Lifetime Marijuana and Alcohol Use, and Cognitive Dysfunction in People with Human Immunodeficiency Virus Infection. Substance Abuse, 39, 116-123. https://doi.org/10.1080/08897077.2017.1391925
|
[23]
|
Cristiani, S.A., Pukay-Martin, N.D. and Bornstein, R.A. (2004) Marijuana Use and Cognitive Function in HIV-Infected People. Journal of Neuropsychiatry and Clinical Neurosciences, 16, 330-335. https://doi.org/10.1176/jnp.16.3.330
|
[24]
|
Watson, C.W., Paolillo, E.W., Morgan, E.E., Umlauf, A., Sundermann, E.E., et al. (2020) Cannabis Exposure Is Associated with a Lower Likelihood of Neurocognitive Impairment in People Living with HIV. Journal of Acquired Immune Deficiency Syndromes, 83, 56-64. https://doi.org/10.1097/QAI.0000000000002211
|
[25]
|
Gonzalez, R., Schuster, R.M., Vassileva, J. and Martin, E.M. (2011) Impact of HIV and a History of Marijuana Dependence on Procedural Learning among Individuals with a History of Substance Dependence. Journal of Clinical and Experimental Neuropsychology, 33, 735-752. https://doi.org/10.1080/13803395.2011.553584
|
[26]
|
Weiland, B.J., Thayer, R.E., Depue, B.E., Sabbineni, A., Bryan, A.D., et al. (2015) Daily Marijuana Use Is Not Associated with Brain Morphometric Measures in Adolescents or Adults. Journal of Neuroscience, 35, 1505-1512. https://doi.org/10.1523/JNEUROSCI.2946-14.2015
|
[27]
|
Lorenzetti, V., Solowij, N., Whittle, S., Fornito, A., Lubman, D.I., et al. (2015) Gross Morphological Brain Changes with Chronic, Heavy Cannabis Use. British Journal of Psychiatry, 206, 77-78. https://doi.org/10.1192/bjp.bp.114.151407
|
[28]
|
Nir, T.M., Jahanshad, N., Ching, C.R.K., Cohen, R.A., Harezlak, J., et al. (2019) Progressive Brain Atrophy in Chronically Infected and Treated HIV+ Individuals. Journal of NeuroVirology, 25, 342-353. https://doi.org/10.1007/s13365-019-00723-4
|
[29]
|
Gaoni, Y. and Mechoulam, R. (1971) Isolation and Structure of Δ1-Tetrahydrocannabinol and Other Neutral Cannabinoids from Hashish. Journal of the American Chemical Society, 93, 217-224. https://doi.org/10.1021/ja00730a036
|
[30]
|
Landfield, P.W., Cadwallader, L.B. and Vinsant, S. (1988) Quantitative Changes in Hippocampal Structure Following Long-Term Exposure to Delta 9-Tetrahydrocannabinol: Possible Mediation by Glucocorticoid Systems. Brain Research, 443, 47-62. https://doi.org/10.1016/0006-8993(88)91597-1
|
[31]
|
Scallet, A.C., Uemura, E., Andrews, A., Ali, S.F., et al. (1987) Morphometric Studies of the Rat Hippocampus Following Chronic Delta-9-Tetrahydrocannabinol (THC). Brain Research, 436, 193-198. https://doi.org/10.1016/0006-8993(87)91576-9
|
[32]
|
Bossong, M.G. and Niesink, R.J. (2010) Adolescent Brain Maturation, the Endogenous Cannabinoid System and the Neurobiology of Cannabis-Induced Schizophrenia. Progress in Neurobiology, 92, 370-385. https://doi.org/10.1016/j.pneurobio.2010.06.010
|
[33]
|
Quinn, H.R., Matsumoto, I., Callaghan, P.D., Long, L.E., Arnold, J.C., et al. (2008) Adolescent Rats Find Repeated Δ9-THC Less Aversive than Adult Rats but Display Greater Residual Cognitive Deficits and Changes in Hippocampal Protein Expression Following Exposure. Neuropsychopharmacology, 33, 1113-1126. https://doi.org/10.1038/sj.npp.1301475
|
[34]
|
Burns, H.D., Van Laere, K., Sanabria-Bohorquez, S., Hamill, T.G., Bormans, G., et al. (2007) [18F]MK-9470, a Positron Emission Tomography (PET) Tracer for in Vivo Human Pet Brain Imaging of the Cannabinoid-1 Receptor. Proceedings of the National Academy of Sciences of the United States of America, 104, 9800-9805. https://doi.org/10.1073/pnas.0703472104
|
[35]
|
Pillay, S.S., Rogowska, J., Kanayama, G., Jon, D.I., Gruber, S., et al. (2004) Neurophysiology of Motor Function Following Cannabis Discontinuation in Chronic Cannabis Smokers: An fMRI Study. Drug and Alcohol Dependence, 76, 261-271. https://doi.org/10.1016/j.drugalcdep.2004.05.009
|
[36]
|
Kanayama, G., Rogowska, J., Pope, H.G., Gruber, S.A. and Yurgelun-Todd, D.A. (2004) Spatial Working Memory in Heavy Cannabis Users: A Functional Magnetic Resonance Imaging Study. Psychopharmacology (Berl), 176, 239-247. https://doi.org/10.1007/s00213-004-1885-8
|
[37]
|
Gruber, S.A. and Yurgelun-Todd, D.A. (2005) Neuroimaging of Marijuana Smokers during Inhibitory Processing: A Pilot Investigation. Cognitive Brain Research, 23, 107-118. https://doi.org/10.1016/j.cogbrainres.2005.02.016
|
[38]
|
Costa, V.D., Lang, P.J., Sabatinelli, D., Versace, F. and Bradley, M.M. (2010) Emotional Imagery: Assessing Pleasure and Arousal in the Brain’s Reward Circuitry. Human Brain Mapping, 31, 1446-1457. https://doi.org/10.1002/hbm.20948
|
[39]
|
Goldstein, R.Z. and Volkow, N.D. (2002) Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex. American Journal of Psychiatry, 159, 1642-1652. https://doi.org/10.1176/appi.ajp.159.10.1642
|
[40]
|
Volkow, N.D., Fowler, J.S. and Wang, G.J. (2003) The Addicted Human Brain: Insights from Imaging Studies. Journal of Clinical Investigation, 111, 1444-1451. https://doi.org/10.1172/JCI18533
|
[41]
|
Chang, L. and Chronicle, E.P. (2007) Functional Imaging Studies in Cannabis Users. The Neuroscientist, 13, 422-432. https://doi.org/10.1177/1073858406296601
|
[42]
|
Chang, L., Yakupov, R., Cloak, C. and Ernst, T. (2006) Marijuana Use Is Associated with a Reorganized Visual-Attention Network and Cerebellar Hypoactivation. Brain, 129, 1096-1112. https://doi.org/10.1093/brain/awl064
|
[43]
|
Filbey, F.M., Aslan, S., Calhoun, V.D., Spence, J.S., Damaraju, E., et al. (2014) Long-Term Effects of Marijuana Use on the Brain. Proceedings of the National Academy of Sciences of the United States of America, 111, 16913-16918. https://doi.org/10.1073/pnas.1415297111
|
[44]
|
Plessis, S.D., Vink, M., Joska, J.A., Koutsilieri, E., Stein, D.J., et al. (2014) HIV Infection and the Fronto-Striatal System: A Systematic Review and Meta-Analysis of fMRI Studies. AIDS, 28, 803-811. https://doi.org/10.1097/QAD.0000000000000151
|
[45]
|
Volkow, N.D., Wang, G.J., Tomasi, D. and Baler, R.D. (2013) Unbalanced Neuronal Circuits in Addiction. Current Opinion in Neurobiology, 23, 639-648. https://doi.org/10.1016/j.conb.2013.01.002
|
[46]
|
Liu, Y., Tang, X.P., McArthur, J.C., Scott, J. and Gartner, S. (2000) Analysis of Human Immunodeficiency Virus Type 1 gp160 Sequences from a Patient with HIV Dementia: Evidence for Monocyte Trafficking into Brain. Journal of NeuroVirology, 6, S70-81.
|
[47]
|
Williams, D.W., Eugenin, E.A., Calderon, T.M. and Berman, J.W. (2012) Monocyte Maturation, HIV Susceptibility, and Transmigration across the Blood Brain Barrier Are Critical in HIV Neuropathogenesis. Journal of Leukocyte Biology, 91, 401-415. https://doi.org/10.1189/jlb.0811394
|
[48]
|
Hong, S. and Banks, W.A. (2015) Role of the Immune System in HIV-Associated Neuroinflammation and Neurocognitive Implications. Brain, Behavior, and Immunity, 45, 1-12. https://doi.org/10.1016/j.bbi.2014.10.008
|
[49]
|
Gonzalez-Scarano, F. and Martin-Garcia, J. (2005) The Neuropathogenesis of AIDS. Nature Reviews Immunology, 5, 69-81. https://doi.org/10.1038/nri1527
|
[50]
|
Thieblemont, N., Weiss, L., Sadeghi, H.M., Estcourt, C. and Haeffner-Cavaillon, N. (1995) CD14lowCD16high: A Cytokine-Producing Monocyte Subset Which Expands during Human Immunodeficiency Virus Infection. European Journal of Immunology, 25, 3418-3424. https://doi.org/10.1002/eji.1830251232
|
[51]
|
Mukherjee, R., Kanti Barman, P., Kumar Thatoi, P., Tripathy, R., Kumar Das, B., et al. (2015) Non-Classical Monocytes Display Inflammatory Features: Validation in Sepsis and Systemic Lupus Erythematous. Scientific Reports, 5, Article No. 13886. https://doi.org/10.1038/srep13886
|
[52]
|
Shikuma, C.M., Seto, T., Liang, C.Y., Bennett, K., DeGruttola, V., et al. (2012) Vitamin D Levels and Markers of Arterial Dysfunction in HIV. AIDS Research and Human Retroviruses, 28, 793-797. https://doi.org/10.1089/aid.2011.0086
|
[53]
|
McIntosh, R.C., Paul, R., Ndhlovu, L.C., Hidalgo, M., Lobo, J.D., et al. (2018) Resting-State Connectivity and Spontaneous Activity of Ventromedial Prefrontal Cortex Predict Depressive Symptomology and Peripheral Inflammation in HIV. Journal of NeuroVirology, 24, 616-628. https://doi.org/10.1007/s13365-018-0658-9
|
[54]
|
Kallianpur, K.J., Gerschenson, M., Mitchell, B.I., LiButti, D.E., Umaki, T.M., et al. (2016) Oxidative Mitochondrial DNA Damage in Peripheral Blood Mononuclear Cells Is Associated with Reduced Volumes of Hippocampus and Subcortical Gray Matter in Chronically HIV-Infected Patients. Mitochondrion, 28, 8-15. https://doi.org/10.1016/j.mito.2016.02.006
|
[55]
|
Cox, R.W. (1996) AFNI: Software for Analysis and Visualization of Functional Magnetic Resonance Neuroimages. Computers and Biomedical Research, 29, 162-173. https://doi.org/10.1006/cbmr.1996.0014
|
[56]
|
Biswal, B., Yetkin, F.Z., Haughton, V.M. and Hyde, J.S. (1995) Functional Connectivity in the Motor Cortex of Resting Human Brain Using Echo-Planar MRI. Magnetic Resonance in Medicine, 34, 537-541. https://doi.org/10.1002/mrm.1910340409
|
[57]
|
Beck, A.T., Ward, C.H., Mendelson, M., Mock, J. and Erbaugh, J. (1961) An Inventory for Measuring Depression. Archives of General Psychiatry, 4, 561-571. https://doi.org/10.1001/archpsyc.1961.01710120031004
|
[58]
|
Ndhlovu, L.C., Umaki, T., Chew, G.M., Chow, D.C., Agsalda, M., et al. (2014) Treatment Intensification with Maraviroc (CCR5 Antagonist) Leads to Declines in CD16-Expressing Monocytes in cART-Suppressed Chronic HIV-Infected Subjects and Is Associated with Improvements in Neurocognitive Test Performance: Implications for HIV-Associated Neurocognitive Disease (HAND). Journal of NeuroVirology, 20, 571-582. https://doi.org/10.1007/s13365-014-0279-x
|
[59]
|
Pfefferbaum, A., Zahr, N.M., Sassoon, S.A., Kwon, D., Pohl, K.M., et al. (2018) Accelerated and Premature Aging Characterizing Regional Cortical Volume Loss in Human Immunodeficiency Virus Infection: Contributions from Alcohol, Substance Use, and Hepatitis C Coinfection. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 3, 844-859. https://doi.org/10.1016/j.bpsc.2018.06.006
|
[60]
|
Holm, S. (1979) A Simple Sequentially Rejective Multiple Test Procedure. Scandinavian Journal of Statistics, 6, 65-70.
|
[61]
|
Cox, R.W., Chen, G., Glen, D.R., Reynolds, R.C. and Taylor, P.A. (2017) fMRI Clustering and False-Positive Rates. Proceedings of the National Academy of Sciences of the United States of America, 114, E3370-E3371. https://doi.org/10.1073/pnas.1614961114
|
[62]
|
Cox, R.W., Chen, G., Glen, D.R., Reynolds, R.C. and Taylor, P.A. (2017) fMRI Clustering in AFNI: False-Positive Rates Redux. Brain Connectivity, 7, 152-171. https://doi.org/10.1089/brain.2016.0475
|
[63]
|
Melrose, R.J., Tinaz, S., Castelo, J.M., Courtney, M.G. and Stern, C.E. (2008) Compromised Fronto-Striatal Functioning in HIV: An fMRI Investigation of Semantic Event Sequencing. Behavioural Brain Research, 188, 337-347. https://doi.org/10.1016/j.bbr.2007.11.021
|
[64]
|
Ipser, J.C., Brown, G.G., Bischoff-Grethe, A., Connolly, C.G., Ellis, R.J., et al. (2015) HIV Infection Is Associated with Attenuated Frontostriatal Intrinsic Connectivity: A Preliminary Study. Journal of the International Neuropsychological Society, 21, 203-213. https://doi.org/10.1017/S1355617715000156
|
[65]
|
Thomas, J.B., Brier, M.R., Snyder, A.Z., Vaida, F.F. and Ances, B.M. (2013) Pathways to Neurodegeneration: Effects of HIV and Aging on Resting-State Functional Connectivity. Neurology, 80, 1186-1193. https://doi.org/10.1212/WNL.0b013e318288792b
|
[66]
|
Wang, X., Foryt, P., Ochs, R., Chung, J.-H., Wu, Y., et al. (2011) Abnormalities in Resting-State Functional Connectivity in Early Human Immunodeficiency Virus Infection. Brain Connectivity, 1, 207-217. https://doi.org/10.1089/brain.2011.0016
|
[67]
|
Thayer, R.E., YorkWilliams, S., Karoly, H.C., Sabbineni, A., Ewing, S.F., et al. (2017) Structural Neuroimaging Correlates of Alcohol and Cannabis Use in Adolescents and Adults. Addiction, 112, 2144-2154. https://doi.org/10.1111/add.13923
|
[68]
|
Martin-Santos, R., Fagundo, A.B., Crippa, J.A., Atakan, Z., Bhattacharyya, S., et al. (2010) Neuroimaging in Cannabis Use: A Systematic Review of the Literature. Psychological Medicine, 40, 383-398. https://doi.org/10.1017/S0033291709990729
|
[69]
|
Gilman, J.M., Kuster, J.K., Lee, S., Lee, M.J., Kim, B.W., et al. (2014) Cannabis Use Is Quantitatively Associated with Nucleus Accumbens and Amygdala Abnormalities in Young Adult Recreational Users. Journal of Neuroscience, 34, 5529-5538. https://doi.org/10.1523/JNEUROSCI.4745-13.2014
|
[70]
|
Schacht, J.P., Hutchison, K.E. and Filbey, F.M. (2012) Associations between Cannabinoid Receptor-1 (CNR1) Variation and Hippocampus and Amygdala Volumes in Heavy Cannabis Users. Neuropsychopharmacology, 37, 2368-2376. https://doi.org/10.1038/npp.2012.92
|
[71]
|
Yücel, M., Solowij, N., Respondek, C., Whittle, S., Fornito, A., et al. (2008) Regional Brain Abnormalities Associated with Long-Term Heavy Cannabis Use. Archives of General Psychiatry, 65, 694-701. https://doi.org/10.1001/archpsyc.65.6.694
|
[72]
|
Cousijn, J., Wiers, R.W., Ridderinkhof, K.R., van den Brink, W., Veltman, D.J., et al. (2012) Grey Matter Alterations Associated with Cannabis Use: Results of a VBM Study in Heavy Cannabis Users and Healthy Controls. NeuroImage, 59, 3845-3851. https://doi.org/10.1016/j.neuroimage.2011.09.046
|
[73]
|
Di Chiara, G. and Imperato, A. (1988) Drugs Abused by Humans Preferentially Increase Synaptic Dopamine Concentrations in the Mesolimbic System of Freely Moving Rats. Proceedings of the National Academy of Sciences of the United States of America, 85, 5274-5278. https://doi.org/10.1073/pnas.85.14.5274
|
[74]
|
Paul, R.H., Brickman, A.M., Navia, B., Hinkin, C., Malloy, P.F., et al. (2005) Apathy Is Associated with Volume of the Nucleus Accumbens in Patients Infected with HIV. Journal of Neuropsychiatry and Clinical Neurosciences, 17, 167-171. https://doi.org/10.1176/jnp.17.2.167
|
[75]
|
Paul, R., Flanigan, T.P., Tashima, K., Cohen, R., Lawrence, J., et al. (2005) Apathy Correlates with Cognitive Function but Not CD4 Status in Patients with Human Immunodeficiency Virus. Journal of Neuropsychiatry and Clinical Neurosciences, 17, 114-118. https://doi.org/10.1176/jnp.17.1.114
|
[76]
|
Woods, S.P., Moore, D.J., Weber, E. and Grant, I. (2009) Cognitive Neuropsy-chology of HIV-Associated Neurocognitive Disorders. Neuropsychology Review, 19, 152-168. https://doi.org/10.1007/s11065-009-9102-5
|
[77]
|
Marcotte, T.D., Lazzaretto, D., Scott, J.C., Roberts, E., Woods, S.P., et al. (2006) Visual Attention Deficits Are Associated with Driving Accidents in Cognitively-Impaired HIV-Infected Individuals. Journal of Clinical and Experimental Neuropsychology, 28, 13-28. https://doi.org/10.1080/13803390490918048
|
[78]
|
Chang, L., Tomasi, D., Yakupov, R., Lozar, C., Arnold, S., et al. (2004) Adaptation of the Attention Network in Human Immunodeficiency Virus Brain Injury. Annals of Neurology, 56, 259-272. https://doi.org/10.1002/ana.20190
|
[79]
|
Ances, B.M., Vaida, F., Yeh, M.J., Liang, C.L., Buxton, R.B., et al. (2010) HIV Infection and Aging Independently Affect Brain Function as Measured by Functional Magnetic Resonance Imaging. Journal of Infectious Diseases, 201, 336-340. https://doi.org/10.1086/649899
|
[80]
|
Wiesman, A.I., O’Neill, J., Mills, M.S., Robertson, K.R., Fox, H.S., et al. (2018) Aberrant Occipital Dynamics Differentiate HIV-Infected Patients with and without Cognitive Impairment. Brain, 141, 1678-1690. https://doi.org/10.1093/brain/awy097
|
[81]
|
Ances, B.M., Sisti, D., Vaida, F., Liang, C.L., Leontiev, O., et al. (2009) Resting Cerebral Blood Flow: A Potential Biomarker of the Effects of HIV in the Brain. Neurology, 73, 702-708. https://doi.org/10.1212/WNL.0b013e3181b59a97
|
[82]
|
Harding, I.H., Solowij, N., Harrison, B.J., Takagi, M., Lorenzetti, V., et al. (2012) Functional Connectivity in Brain Networks Underlying Cognitive Control in Chronic Cannabis Users. Neuropsychopharmacology, 37, 1923-1933. https://doi.org/10.1038/npp.2012.39
|
[83]
|
Hart, C.L., van Gorp, W., Haney, M., Foltin, R.W. and Fischman, M.W. (2001) Effects of Acute Smoked Marijuana on Complex Cognitive Performance. Neuropsychopharmacology, 25, 757-765. https://doi.org/10.1016/S0893-133X(01)00273-1
|
[84]
|
Nordstrom, B.R. and Hart, C.L. (2006) Assessing Cognitive Functioning in Cannabis Users: Cannabis Use History an Important Consideration. Neuropsychopharmacology, 31, 2798-2799. (Author Reply 2800-2791) https://doi.org/10.1038/sj.npp.1301210
|
[85]
|
Ramaekers, J.G., Kauert, G., Theunissen, E.L., Toennes, S.W. and Moeller, M.R. (2009) Neurocognitive Performance during Acute THC Intoxication in Heavy and Occasional Cannabis Users. Journal of Psychopharmacology, 23, 266-277. https://doi.org/10.1177/0269881108092393
|
[86]
|
Wetherill, R.R., Fang, Z., Jagannathan, K., Childress, A.R., Rao, H., et al. (2015) Cannabis, Cigarettes, and Their Co-Occurring Use: Disentangling Differences in Default Mode Network Functional Connectivity. Drug and Alcohol Dependence, 153, 116-123. https://doi.org/10.1016/j.drugalcdep.2015.05.046
|
[87]
|
Byrd, D.A., Fellows, R.P., Morgello, S., Franklin, D., Heaton, R.K., et al. (2011) Neurocognitive Impact of Substance Use in HIV Infection. Journal of Acquired Immune Deficiency Syndromes, 58, 154-162. https://doi.org/10.1097/QAI.0b013e318229ba41
|
[88]
|
Grotenhermen, F. and Muller-Vahl, K. (2012) The Therapeutic Potential of Cannabis and Cannabinoids. Deutsches Ärzteblatt International, 109, 495-501. https://doi.org/10.3238/arztebl.2012.0495
|
[89]
|
Toborek, M., Lee, Y.W., Flora, G., Pu, H., Andras, I.E., et al. (2005) Mechanisms of the Blood-Brain Barrier Disruption in HIV-1 Infection. Cellular and Molecular Neurobiology, 25, 181-199. https://doi.org/10.1007/s10571-004-1383-x
|
[90]
|
Dietrich, J.B. (2002) The Adhesion Molecule ICAM-1 and Its Regulation in Relation with the Blood-Brain Barrier. Journal of Neuroimmunology, 128, 58-68. https://doi.org/10.1016/S0165-5728(02)00114-5
|
[91]
|
Brown, E.J. (1997) Adhesive Interactions in the Immune System. Trends in Cell Biology, 7, 289-295. https://doi.org/10.1016/S0962-8924(97)01076-3
|
[92]
|
Floris, S., Ruuls, S.R., Wierinckx, A., van der Pol, S.M., Dopp, E., et al. (2002) Interferon-Beta Directly Influences Monocyte Infiltration into the Central Nervous System. Journal of Neuroimmunology, 127, 69-79. https://doi.org/10.1016/S0165-5728(02)00098-X
|
[93]
|
Eugenin, E.A., Osiecki, K., Lopez, L., Goldstein, H., Calderon, T.M., et al. (2006) CCL2/Monocyte Chemoattractant Protein-1 Mediates Enhanced Transmigration of Human Immunodeficiency Virus (HIV)-Infected Leukocytes across the Blood-Brain Barrier: A Potential Mechanism of HIV-CNS Invasion and NeuroAIDS. Journal of Neuroscience, 26, 1098-1106. https://doi.org/10.1523/JNEUROSCI.3863-05.2006
|
[94]
|
Yao, Y. and Tsirka, S.E. (2014) Monocyte Chemoattractant Protein-1 and the Blood-Brain Barrier. Cellular and Molecular Life Sciences, 71, 683-697. https://doi.org/10.1007/s00018-013-1459-1
|
[95]
|
Woods, S.P., Morgan, E.E., Marquie-Beck, J., Carey, C.L., Grant, I., et al. (2006) Markers of Macrophage Activation and Axonal Injury Are Associated with Prospective Memory in HIV-1 Disease. Cognitive and Behavioral Neurology, 19, 217-221. https://doi.org/10.1097/01.wnn.0000213916.10514.57
|
[96]
|
Rizzo, M.D., Crawford, R.B., Henriquez, J.E., Aldhamen, Y.A., Gulick, P., et al. (2018) HIV-Infected Cannabis Users Have Lower Circulating CD16+ Monocytes and IFN-Gamma-Inducible Protein 10 Levels Compared with Nonusing HIV Patients. AIDS, 32, 419-429.
|
[97]
|
Passlick, B., Flieger, D. and Ziegler-Heitbrock, H.W. (1989) Identification and Characterization of a Novel Monocyte Subpopulation in Human Peripheral Blood. Blood, 74, 2527-2534. https://doi.org/10.1182/blood.V74.7.2527.2527
|
[98]
|
Thomas, G., Tacke, R., Hedrick, C.C. and Hanna, R.N. (2015) Nonclassical Patrolling Monocyte Function in the Vasculature. Arteriosclerosis, Thrombosis, and Vascular Biology, 35, 1306-1316. https://doi.org/10.1161/ATVBAHA.114.304650
|
[99]
|
Williams, D.W., Anastos, K., Morgello, S. and Berman, J.W. (2015) JAM-A and ALCAM Are Therapeutic Targets to Inhibit Diapedesis across the BBB of CD14+ CD16+ Monocytes in HIV-Infected Individuals. Journal of Leukocyte Biology, 97, 401-412. https://doi.org/10.1189/jlb.5A0714-347R
|
[100]
|
Williams, D.W., Calderon, T.M., Lopez, L., Carvallo-Torres, L., Gaskill, P.J., et al. (2013) Mechanisms of HIV Entry into the CNS: Increased Sensitivity of HIV Infected CD14+CD16+ Monocytes to CCL2 and Key Roles of CCR2, JAM-A, and ALCAM in Diapedesis. PLoS ONE, 8, e69270. https://doi.org/10.1371/journal.pone.0069270
|
[101]
|
Crowe, S., Zhu, T. and Muller, W.A. (2003) The Contribution of Monocyte Infection and Trafficking to Viral Persistence, and Maintenance of the Viral Reservoir in HIV Infection. Journal of Leukocyte Biology, 74, 635-641. https://doi.org/10.1189/jlb.0503204
|
[102]
|
Williams, J.C., Appelberg, S., Goldberger, B.A., Klein, T.W., Sleasman, J.W., et al. (2014) Δ9-Tetrahydrocannabinol Treatment during Human Monocyte Differentiation Reduces Macrophage Susceptibility to HIV-1 Infection. Journal of Neuroimmune Pharmacology, 9, 369-379. https://doi.org/10.1007/s11481-014-9527-3
|
[103]
|
Braga, R.J., Burdick, K.E., Derosse, P. and Malhotra, A.K. (2012) Cognitive and Clinical Outcomes Associated with Cannabis Use in Patients with Bipolar I Disorder. Psychiatry Research, 200, 242-245. https://doi.org/10.1016/j.psychres.2012.05.025
|
[104]
|
Ringen, P.A., Vaskinn, A., Sundet, K., Engh, J.A., Jonsdottir, H., et al. (2010) Opposite Relationships between Cannabis Use and Neurocognitive Functioning in Bipolar Disorder and Schizophrenia. Psychological Medicine, 40, 1337-1347. https://doi.org/10.1017/S0033291709991620
|
[105]
|
Gruber, S.A., Sagar, K.A., Dahlgren, M.K., Racine, M.T., Smith, R.T., et al. (2016) Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function. Frontiers in Pharmacology, 7, 355. https://doi.org/10.3389/fphar.2016.00355
|
[106]
|
Rosen, A.S., Sodos, L.M., Hirst, R.B., Vaughn, D. and Lorkiewicz, S.A. (2018) Cream of the Crop: Clinical Representativeness of Eligible and Ineligible Cannabis Users in Research. Substance Use & Misuse, 53, 1937-1950. https://doi.org/10.1080/10826084.2018.1441312
|